Article Text
Abstract
“No one has advanced a just and logical reason why reward for service to the public should be extended to the inventor of a mechanical toy and denied to the genius whose patience, foresight, and effort have given a valuable new [discovery] to mankind” (Katopis CJ. Patents v patents: policy implications of recent patent legislation. St John’s Law Review 1997;71:329). The law around the world permits the granting of patents for drugs, medical devices, and cosmetic treatment of the human body. At the same time, patentability for a method of treatment of the same body is denied in some countries on various public policy grounds. Is there any logical justification for this distinction? Are methods of medical treatment not as vital to the health or even to the life of a patient as drugs or medical devices? Why is a cosmetic result patentable and a curative result not?
- patents
- patent law
- patenting of medical treatment methods
Statistics from Altmetric.com
Footnotes
-
↵† In this article, the terms “morality” and “ethics” are used as defined by The Oxford English Dictionary. The term “ordre public”, derived from French law, is not easy to translate into English, and therefore the original French term is used in the TRIPS agreement. It expresses concerns about matters threatening the social structures which tie a society together.
-
↵‡ Note that article 53(a) EPC also expressly excludes patenting of inventions where their publication or exploitation would be contrary to ordre public and morality.
-
The authors request any comments or opinions that readers may have on the issues they have raised. These should be directed to O Mitnovetski: Oksana.Mitnovetskiaar.com.au
Read the full text or download the PDF:
Other content recommended for you
- The COVID-19 vaccine patent: a right without rationale
- Pregabalin: what the patent litigation means for doctors and drug companies
- “World’s pharmacy” faces new challenges from Western drug companies
- Novartis challenges India’s drug patent laws in Supreme Court
- Decolonising human rights: how intellectual property laws result in unequal access to the COVID-19 vaccine
- The impact of intellectual property regulation on global medical technology innovation
- Patent wars: affordable medicines versus intellectual property rights
- Human-tissue-related inventions: ownership and intellectual property rights in international collaborative research in developing countries
- Healing an ailing pharmaceutical system: prescription for reform for United States and Canada
- Global equitable access to vaccines, medicines and diagnostics for COVID-19: The role of patents as private governance